CHRONIC MORPHINE INCREASES CALBINDIN D-28K IN RAT STRIATUM - POSSIBLENMDA RECEPTOR INVOLVEMENT

Citation
Mm. Garcia et Re. Harlan, CHRONIC MORPHINE INCREASES CALBINDIN D-28K IN RAT STRIATUM - POSSIBLENMDA RECEPTOR INVOLVEMENT, NeuroReport, 5(1), 1993, pp. 65-68
Citations number
20
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
09594965
Volume
5
Issue
1
Year of publication
1993
Pages
65 - 68
Database
ISI
SICI code
0959-4965(1993)5:1<65:CMICDI>2.0.ZU;2-5
Abstract
THE neuronal intracellular calcium-binding protein calbindin D-28k is a neurochemical marker in the striatum. normally expressed in the matr ix compartment and absent from the mu-opiate receptor-enriched strioso mal (patch) compartment. Because chronic treatment with morphine has b een reported to increase calcium levels in synaptosomes of rat striatu m, we studied effects of morphine on calbindin immunoreactivity (ir) i n rat brain, using immunocytochemistry. Treatment with morphine for 5 days increased calbindin-ir in the striatal matrix, and induced intens e calbindin-ir in the patch compartment. Increased calbindin-ir in pat ches persisted through day 14 post-morphine. Co-administration of the NMDA receptor antagonist MK-801 blocked the morphine-induced increase in calbindin-ir in patches. We suggest that chronic morphine treatment may increase calcium and calbindin levels via increased glutamatergic transmission in striatum. These findings are consistent with reports that MK-801 inhibits tolerance to morphine, and provide a possible mec hanism and anatomical substrate for this inhibition.